- What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?
-
Aslan K, Meydanli MM
- KMID: 2526150
- J Gynecol Oncol.
- 2021 Sep;32(5):e88.
- doi: 10.3802/jgo.2021.32.e88
-
- CITED
-
- Close
- SHARE
-
- Close
- Does polycystic ovary syndrome independently affect oncologic and reproductive outcomes in patients with endometrial cancer receiving fertility-sparing treatment?
-
Harada M, Osuga Y
- KMID: 2526149
- J Gynecol Oncol.
- 2021 Sep;32(5):e80.
- doi: 10.3802/jgo.2021.32.e80
-
- CITED
-
- Close
- SHARE
-
- Close
- Author's reply to: What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?
-
Tortorella L, Scambia G, Fanfani F
- KMID: 2526151
- J Gynecol Oncol.
- 2021 Sep;32(5):e89.
- doi: 10.3802/jgo.2021.32.e89
-
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program
-
Bui CN, Hong S, Suh M, Jun JK, Jung KW, Lim MC, Choi KS
- KMID: 2526145
- J Gynecol Oncol.
- 2021 Sep;32(5):e81.
- doi: 10.3802/jgo.2021.32.e81
Objective We aimed to determine the differences in stage at diagnosis of cervical cancer among Korean women according to screening history. Methods Using linkage data from the Korean Central Cancer Registry and Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features
-
Kim N, Park W, Cho WK, Bae DS, Kim BG, Lee JW, Choi CH, Kim TJ, Lee YY
- KMID: 2526138
- J Gynecol Oncol.
- 2021 Sep;32(5):e72.
- doi: 10.3802/jgo.2021.32.e72
Objective Unlike cervical squamous cell carcinoma, there are no consensus criteria for serum tumor markers in cervical adenocarcinoma. This study aimed to identify the prognostic value of preoperative carbohydrate antigen 125... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy
-
Onal C, Guler OC, Reyhan M, Yapar AF
- KMID: 2526144
- J Gynecol Oncol.
- 2021 Sep;32(5):e74.
- doi: 10.3802/jgo.2021.32.e74
Objective We investigated the importance of metabolic parameters measured with 18F-fluorodeoxyglucose positron-emission tomography integrated with computed tomography (FDG-PET/CT) for predicting progression-free survival (PFS) and overall survival (OS) in cervical cancer with... -
- CITED
-
- Close
- SHARE
-
- Close
- Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
-
Fujiwara K, Fujiwara H, Yoshida H, Satoh T, Yonemori K, Nagao S, Matsumoto T, Kobayashi H, Bourgeois H, Harter P, Mosconi AM, Vazquez IP, Reinthaller A, Fujita T, Rowe P, Pujade-Lauraine E, Ray-Coquard I
- KMID: 2526133
- J Gynecol Oncol.
- 2021 Sep;32(5):e82.
- doi: 10.3802/jgo.2021.32.e82
Objective The addition of maintenance olaparib to bevacizumab demonstrated a significant progression-free survival (PFS) benefit in patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1/ENGOT-ov25 trial (NCT02477644). We evaluated maintenance... -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome
-
Wang L, Luo X, Wang Q, Lv Q, Wu P, Liu W, Chen X
- KMID: 2526146
- J Gynecol Oncol.
- 2021 Sep;32(5):e70.
- doi: 10.3802/jgo.2021.32.e70
Objective This study aimed to investigate the impact of polycystic ovary syndrome (PCOS) on fertility-sparing treatment in young patients with atypical endometrial hyperplasia (AEH) or endometrioid endometrial cancer (EEC). Methods A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology
-
Ikeda M, Mikami M, Yasaka M, Enomoto T, Kobayashi Y, Nagase S, Yokoyama N, Katabuchi H
- KMID: 2526134
- J Gynecol Oncol.
- 2021 Sep;32(5):e68.
- doi: 10.3802/jgo.2021.32.e68
Objective The Japan Society of Obstetrics and Gynecology conducted a retrospective multi-institutional survey of patients who underwent cervical conization in Japan. This study aimed to determine the predictive factors for positive... -
- CITED
-
- Close
- SHARE
-
- Close
- Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway
-
Xiao L, Shi XY, Li ZL, Li M, Zhang MM, Yan SJ, Wei ZL
- KMID: 2526147
- J Gynecol Oncol.
- 2021 Sep;32(5):e77.
- doi: 10.3802/jgo.2021.32.e77
Background Some long non-coding RNAs (lncRNAs) have been found to contribute to cisplatin resistance. Here, we identified a novel lncRNA that was downregulated in cisplatin-resistant to ovarian cancer (OC) cells and... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis
-
Yoshihara M, Tamauchi S, Iyoshi S, Kitami K, Uno K, Mogi K, Kajiyama H
- KMID: 2526132
- J Gynecol Oncol.
- 2021 Sep;32(5):e66.
- doi: 10.3802/jgo.2021.32.e66
Objective The aim of the present study was to examine the effects of incomplete surgery and adjuvant chemotherapy on the prognosis of patients with intraoperative rupture of capsulated stage I epithelial... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study
-
Park SJ, Yim GW, Paik H, Lee N, Lee S, Lee M, Kim HS
- KMID: 2526148
- J Gynecol Oncol.
- 2021 Sep;32(5):e73.
- doi: 10.3802/jgo.2021.32.e73
Background The second-line chemotherapy using paclitaxel, carboplatin, and bevacizumab for treating platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer frequently cause chemotherapy-induced peripheral neuropathy (CIPN), which is significantly associated with deterioration... -
- CITED
-
- Close
- SHARE
-
- Close
